Respiratory Distress Syndrome clinical trials at UC Health
3 in progress, 1 open to new patients
Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome
“The study team wants to know if adding a sigh-type of breath to a ventilator reduces chances of developing more serious lung problems.”
open to eligible people ages 18-89
A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease the number of days they require invasive mechanical ventilation.
Sorry, not yet accepting patients
This is a Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of a single dose of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion in patients with Acute Respiratory Distress Syndrome (ARDS). This study is the extension of the Phase 1 pilot study (NCT01775774) and Phase 2a study (NCT02097641).
Study of Higher breathing machine pressure settings with/without muscle relaxant for Acute Respiratory Distress Syndrome (ARDS)
“Does early treatment with muscle relaxant improve recovery from lung injury?”
Sorry, in progress, not accepting new patients
This study evaluates whether giving a neuromuscular blocker (skeletal muscle relaxant) to a patient with acute respiratory distress syndrome will improve survival. Half of the patients will receive a neuromuscular blocker for two days and in the other half the use of neuromuscular blockers will be discouraged .
at UCSF UCLA UC Davis